Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A IN8BIO, INC. Filed by: LYTTON LAURENCE W

August 13, 2026 2:22 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The shares of the Common Stock reported herein consist of 327,892 shares of Common Stock and warrants to purchase 1,092,753 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 9,847,089 shares of Common Stock outstanding on May 4, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares of the Common Stock reported herein consist of 327,892 shares of Common Stock and warrants to purchase 1,092,753 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 9,847,089 shares of Common Stock outstanding on May 4, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2026.


SCHEDULE 13G



LYTTON LAURENCE W
Signature:/s/ Laurence W Lytton
Name/Title:Reporting Person
Date:08/13/2026
LYTTON-KAMBARA FOUNDATION
Signature:/s/ Laurence W Lytton
Name/Title:President
Date:08/13/2026
Exhibit Information

EXHIBIT 99.1 - AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G

ATTACHMENTS / EXHIBITS

AGREEMENT REGARDING JOINT FILING

Categories

SEC Filings